Why Eli Lilly Stock Is Under Pressure Today | Nasdaq

Shares of Eli Lilly (NYSE: LLY)are tumbling Thursday morning. Specifically, the drugmaker's stock was down by a hefty 6.6% on heavy volume as of 11:15 a.m. ET Thursday. What's sparking this downward slide? Ahead of the opening bell, Lilly announced its 2022 fourth-quarter financial results. The … See more

6%
OFF

Why Eli Lilly Stock Is Under Pressure Today | Nasdaq

2 weeks from now

nasdaq.com

6%
OFF

Why Eli Lilly Stock Is Under Pressure Today | Nasdaq

2 weeks from now

Shares of the pharmaceutical titan Eli Lilly fell by as much as 3.6% on average volume in early-morning trading Wednesday. The drugmaker's stock has since recovered to a degree, but it …

nasdaq.com

3%
OFF

Why Eli Lilly Stock Is Sinking Today - Nasdaq

2 weeks from now

Oct 30, 2024 · Shares of Eli Lilly (NYSE: LLY) were sinking 6.3% lower as of 11:11 a.m. ET on Wednesday. The sharp decline came after the big drugmaker announced its third-quarter …

nasdaq.com

5%
OFF

Why Eli Lilly Stock Beat The Market Today While ResMed And …

2 weeks from now

Apr 17, 2024 · Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical giant (by 0.5%) on Wednesday, leaving several rivals in …

yahoo.com

07%
OFF

Why The Market Dipped But Eli Lilly (LLY) Gained Today

2 weeks from now

6 days ago · In the latest trading session, Eli Lilly (LLY Quick Quote LLY - Free Report) closed at $773.29, marking a +1.07% move from the previous day. The stock outpaced the S&P 500's …

zacks.com

6%
OFF

Why Eli Lilly Stock Is Under Pressure Today

2 weeks from now

Apr 26, 2023 · Shares of the pharmaceutical titan Eli Lilly (NYSE: LLY) fell by as much as 3.6% on average volume in early-morning trading Wednesday. The drugmaker's stock has since …

theglobeandmail.com

19%
OFF

Why Eli Lilly (LLY) Dipped More Than Broader Market Today

2 weeks from now

Dec 30, 2024 · Eli Lilly (LLY) closed at $773.84 in the latest trading session, marking a -1.19% move from the prior day. The stock's change was less than the S&P 500's daily loss of 1.07%. …

nasdaq.com

13%
OFF

LLY Stock Alert: Why Are Eli Lilly Shares Surging Today?

2 weeks from now

Aug 8, 2024 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eli Lilly (NYSE:LLY) stock rose 13% overnight after it beat analyst estimates a...

businessinsider.com

20%
OFF

Down More Than 20% From Its High, Is Now The Time To Buy Eli …

2 weeks from now

Nov 28, 2024 · Eli Lilly (LLY 1.07%) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been …

fool.com

20%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

2 weeks from now

Nov 8, 2024 · During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall …

yahoo.com

07%
OFF

Why The Market Dipped But Eli Lilly (LLY) Gained Today - Nasdaq

2 weeks from now

5 days ago · In the latest trading session, Eli Lilly (LLY) closed at $773.29, marking a +1.07% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.11%. On the …

nasdaq.com

19%
OFF

Why Eli Lilly (LLY) Dipped More Than Broader Market Today

2 weeks from now

Dec 30, 2024 · Eli Lilly (LLY Quick Quote LLY - Free Report) closed at $773.84 in the latest trading session, marking a -1.19% move from the prior day. The stock's change was less than …

zacks.com

3%
OFF

Why Eli Lilly Stock Climbed Today - Nasdaq

2 weeks from now

May 16, 2022 · As of 1:50 p.m. ET, Eli Lilly's stock price was up more than 3%. ... Why Eli Lilly Stock Climbed Today ... which will be marketed under the brand name Mounjaro, helps to …

nasdaq.com

4%
OFF

Why Eli Lilly Stock Jumped By 4% Today - Nasdaq

2 weeks from now

May 6, 2024 · The largest pharmaceutical company in the world by market cap, Eli Lilly (NYSE: LLY), is continuing to share some of its profits with shareholders. The company has kept its …

nasdaq.com

FAQs about Why Eli Lilly Stock Is Under Pressure Today | Nasdaq Coupon?

What happened to Eli Lilly's share price?

Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical giant (by 0.5%) on Wednesday, leaving several rivals in the dust. These included device makers ResMed (NYSE: RMD), whose stock suffered a 6% blow, and AdaptHealth (NASDAQ: AHCO), with a nearly 2% decline. ...

Is Eli Lilly a good stock to buy?

Eli Lilly (NYSE: LLY) stock eked out a gain on the stock market Wednesday, but the company doesn't necessarily have itself to thank for this. One of its rival pharmaceutical companies posted strong annual results fueled largely by a product category Lilly is entering. ...

Why did Eli Lilly stock rise 13% overnight?

Eli Lilly (NYSE: LLY) stock rose 13% overnight after it beat analyst estimates and raised guidance. The company’s GLP-1 drugs for diabetes and weight loss, Zepbound and Mounjaro, propelled the results. The company reported net income of $2.97 billion, $3.28 per share fully diluted, on revenue of $11.3 billion. ...

Did the market overreact to Lilly's Q3 earnings miss?

The market overreacted to Lilly's Q3 earnings miss and full-year guidance cut. High-flying aircraft experience turbulence from time to time. It's the same story with stocks. We saw that happen with Eli Lilly (LLY -2.02%) this week. Lilly announced its third-quarter results on Wednesday. Investors didn't like what they heard. ...

Why do investors like Eli Lilly's Q1 update?

Investors like it when companies top quarterly earnings expectations. But they love it when companies have an earnings beat and raise guidance. Eli Lilly did both in its Q1 update. Lilly increased its 2024 full-year revenue outlook to a range of $42.4 billion to $43.6 billion, $2 billion higher than its previous guidance. ...

Why did Lilly's shares sank after its Q3 update?

It's not surprising that Lilly's shares sank after its Q3 update. The drugmaker badly missed Wall Street's revenue and earnings estimates. Lilly cut its full-year earnings guidance. However, a little digging into the rest of the story convinced me that the initial concerns about Lilly's Q3 update are overblown. ...